Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Acta Diabetologica
|
February 9, 2019
Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler? An answer
G Bax, F Bellavere
Minerva Endocrinologica
|
July 1, 1988
[Role of neurotransmitters (VIP, PP and GIP) in diabetic autonomic neuropathies]
D Fedele, G Bax, F Bellavere
Eye (London, England)
|
August 5, 2006
Cellular retention on diagnostic contact lenses: an evaluation of current cleaning protocol
M MacRae, G Bax, B Dhillon
Diabetes, Nutrition & Metabolism
|
April 11, 2002
Experience with sildenafil in diabetes
D Fedele, M Lamonica, G Bax
Diabetes Care
|
August 1, 1996
Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds
G Bax, C Fagherazzi, F Piarulli, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity
R Capdeville, B Mousson, G Bax, et al.
Diabetes Care
|
July 8, 1998
Rigiscan evaluation of specific nervous impairment in patients with diabetes and erectile disorders
G Bax, N Marin, F Piarulli, et al.
Diabetes Care
|
April 1, 1995
Early involvement of central nervous system in type I diabetic patients
G Bax, S Lelli, U Grandis, et al.
Diabetologia
|
December 15, 2012
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial
E Bosi, G Bax, L Scionti, et al.
British Heart Journal
|
March 1, 1988
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?
F Bellavere, M Ferri, L Guarini, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Acta Diabetologica
|
February 9, 2019
Diagnosis of cardiovascular autonomic neuropathy in diabetes: as simple as possible, but not simpler? An answer
G Bax, F Bellavere
Minerva Endocrinologica
|
July 1, 1988
[Role of neurotransmitters (VIP, PP and GIP) in diabetic autonomic neuropathies]
D Fedele, G Bax, F Bellavere
Eye (London, England)
|
August 5, 2006
Cellular retention on diagnostic contact lenses: an evaluation of current cleaning protocol
M MacRae, G Bax, B Dhillon
Diabetes, Nutrition & Metabolism
|
April 11, 2002
Experience with sildenafil in diabetes
D Fedele, M Lamonica, G Bax
Diabetes Care
|
August 1, 1996
Reproducibility of Michigan Neuropathy Screening Instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds
G Bax, C Fagherazzi, F Piarulli, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity
R Capdeville, B Mousson, G Bax, et al.
Diabetes Care
|
July 8, 1998
Rigiscan evaluation of specific nervous impairment in patients with diabetes and erectile disorders
G Bax, N Marin, F Piarulli, et al.
Diabetes Care
|
April 1, 1995
Early involvement of central nervous system in type I diabetic patients
G Bax, S Lelli, U Grandis, et al.
Diabetologia
|
December 15, 2012
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial
E Bosi, G Bax, L Scionti, et al.
British Heart Journal
|
March 1, 1988
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?
F Bellavere, M Ferri, L Guarini, et al.
Page
of 2